Therapeutic potential of hepatocyte growth factor for treating neurological diseases

Current Drug Therapy

Volumn 6, Issue 3, 2011, Pages 197-206

  Kadoyama, Keiichi ^a,b   Kadoyama, Kaori ^c   Funakoshi, Hiroshi ^b,e   Nakamura, Toshikazu ^d   Sakaeda, Toshiyuki ^c  

^a HIMEJI DOKKYO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); C Met; HGF; Neurotrophic; Spinal cord injury (SCI)

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE; RECOMBINANT SCATTER FACTOR; RILUZOLE; RIVASTIGMINE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TACRINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; BRAIN CORTEX; BRAIN ISCHEMIA; CELL DEATH; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DOPAMINERGIC ACTIVITY; HEARING IMPAIRMENT; HIPPOCAMPUS; HUMAN; HYDROCEPHALUS; IN VITRO STUDY; IN VIVO STUDY; MESENCEPHALON; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PARASYMPATHETIC FUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RETINA INJURY; REVIEW; SEIZURE; SPINAL CORD INJURY; SYMPATHETIC FUNCTION;

EID: 79957964587     PISSN: 15748855     EISSN: 10657630     Source Type: Journal    
DOI: 10.2174/157488511796391942     Document Type: Review

References (116)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-1162.
2. Simi A, Ibanez CF. Assembly and activation of neurotrophic factor receptor complexes. Dev Neurobiol 2010; 70: 323-331.
3. Funakoshi H, Belluardo N, Arenas E, et al. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 1995; 268: 1495-1499.
4. Funakoshi H, Risling M, Carlstedt T, et al. Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons. Proc Natl Acad Sci USA 1998; 95: 5269-5274.
5. Nakamura T. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration. Princess Takamatsu Symp 1994; 24: 195-213.
6. Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003; 327: 1-23.
7. Nakamura T. Hepatocyte growth factor and Met receptor, from discovery and the therapeutic implications. Curr Signal Transduct Ther 2011; 6(2): 210-220.
8. Funakoshi H, Nakamura T. Hepatocyte growth factor (HGF): Neurotrophic function and therapeutic implication for neuronal injury/diseases. Curr Signal Transduct Ther 2011; 6(2): in press.
9. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459.
10. Russell WE, McGowan JA, Bucher NL. Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol 1984; 119: 183-192.
11. Luetteke NC, Michalopoulos GK. Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells. Cancer Res 1985; 45: 6331-6337.
12. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986; 83: 6489-6493.
13. Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-419.
14. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443.
15. Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-973.
16. Tashiro K, Hagiya M, Nishizawa T, et al. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci USA 1990; 87: 3200-3204.
17. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239-242.
18. Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001-7005.
19. Konishi T, Takehara T, Tsuji T, et al. Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor. Biochem Biophys Res Commun 1991; 180: 765-773.
20. Naldini L, Tamagnone L, Vigna E, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992; 11: 4825-4833.
21. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804.
22. Naldini L, Vigna E, Narsimhan RP, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991; 6: 501-504.
23. Higuchi O, Mizuno K, Vande Woude GF, Nakamura T. Expression of c-met proto-oncogene in COS cells induces the signal transducing high-affinity receptor for hepatocyte growth factor. FEBS Lett 1992; 301: 282-286.
24. Ferracini R, Longati P, Naldini L, et al. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J Biol Chem 1991; 266: 19558-19564.
25. Longati P, Bardelli A, Ponzetto C, et al. Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 1994; 9: 49-57.
26. Gandino L, Longati P, Medico E, et al. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J Biol Chem 1994; 269: 1815-1820.
27. Hashigasako A, Machide M, Nakamura T, et al. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 2004; 279: 26445-26452.
28. Kadoyama K, Funakoshi H, Ohya-Shimada W, et al. Diseasedependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS. Neurosci Res 2009; 65: 194-200.
29. Furge KA, Zhang YW, Vande Woude GF. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 2000; 19: 5582-5589.
30. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4: 915-925.
31. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600.
32. Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 1999; 2: 213-217.
33. Jung W, Castren E, Odenthal M, et al. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 1994; 126: 485-494.
34. Honda S, Kagoshima M, Wanaka A, et al. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res 1995; 32: 197-210.
35. Achim CL, Katyal S, Wiley CA, et al. Expression of HGF and cMet in the developing and adult brain. Brain Res Dev Brain Res 1997; 102: 299-303.
36. Thewke DP, Seeds NW. The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus. Brain Res 1999; 821: 356-367.
37. Sun W, Funakoshi H, Nakamura T. Differential expression of hepatocyte growth factor and its receptor, c-Met in the rat retina during development. Brain Res 1999; 851: 46-53.
38. Korhonen L, Sjoholm U, Takei N, et al. Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons. Eur J Neurosci 2000; 12: 3453-3461.
39. Funakoshi H, Nakamura T. Identification of HGF-like protein as a novel neurotrophic factor for avian dorsal root ganglion sensory neurons. Biochem Biophys Res Commun 2001; 283: 606-612.
40. Sun W, Funakoshi H, Nakamura T. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res Mol Brain Res 2002; 103: 36-48.
41. Kadoyama K, Funakoshi H, Ohya W, Nakamura T. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci Res 2007; 59: 446-456.
42. Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci 2002; 22: 6537-6548.
43. Kato S, Funakoshi H, Nakamura T, et al. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation. Acta Neuropathol 2003; 106: 112-120.
44. Ohya W, Funakoshi H, Kurosawa T, Nakamura T. Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res 2007; 1147: 51-65.
45. Kitamura K, Iwanami A, Nakamura M, et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res 2007; 85: 2332-2342.
46. Di Renzo MF, Bertolotto A, Olivero M, et al. Selective expression of the Met/HGF receptor in human central nervous system microglia. Oncogene 1993; 8: 219-222.
47. Yamada T, Tsubouchi H, Daikuhara Y, et al. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 1994; 637: 308-312.
48. Hamanoue M, Takemoto N, Matsumoto K, et al. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 1996; 43: 554-564.
49. Gutierrez H, Dolcet X, Tolcos M, Davies A. HGF regulates the development of cortical pyramidal dendrites. Development 2004; 131: 3717-3726.
50. Ebens A, Brose K, Leonardo ED, et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 1996; 17: 1157-1172.
51. Yamamoto Y, Livet J, Pollock RA, et al. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons. Development 1997; 124: 2903-2913.
52. Novak KD, Prevette D, Wang S, et al. Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo. J Neurosci 2000; 20: 326-337.
53. Maina F, Hilton MC, Andres R, et al. Multiple roles for hepatocyte growth factor in sympathetic neuron development. Neuron 1998; 20: 835-846.
54. Maina F, Hilton MC, Ponzetto C, et al. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev 1997; 11: 3341-3350.
55. Thompson J, Dolcet X, Hilton M, et al. HGF promotes survival and growth of maturing sympathetic neurons by PI-3 kinase-and MAP kinase-dependent mechanisms. Mol Cell Neurosci 2004; 27: 441-452.
56. Yang XM, Toma JG, Bamji SX, et al. Autocrine hepatocyte growth factor provides a local mechanism for promoting axonal growth. J Neurosci 1998; 18: 8369-8381.
57. Davey F, Hilton M, Davies AM. Cooperation between HGF and CNTF in promoting the survival and growth of sensory and parasympathetic neurons. Mol Cell Neurosci 2000; 15: 79-87.
58. Nakano M, Takagi N, Takagi K, et al. Hepatocyte growth factor promotes the number of PSD-95 clusters in young hippocampal neurons. Exp Neurol 2007; 207: 195-202.
59. Akita H, Takagi N, Ishihara N, et al. Hepatocyte growth factor improves synaptic localization of the NMDA receptor and intracellular signaling after excitotoxic injury in cultured hippocampal neurons. Exp Neurol 2008; 210: 83-94.
60. Machide M, Kamitori K, Kohsaka S. Hepatocyte growth factorinduced differential activation of phospholipase cgamma 1 and phosphatidylinositol 3-kinase is regulated by tyrosine phosphatase SHP-1 in astrocytes. J Biol Chem 2000; 275: 31392-31398.
61. Yan H, Rivkees SA. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 2002; 69: 597-606.
62. Benkhoucha M, Santiago-Raber ML, Schneiter G, et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2010; 107: 6424-6429.
63. Petty MA, Wettstein JG. Elements of cerebral microvascular ischaemia. Brain Res Brain Res Rev 2001; 36: 23-34.
64. Miyazawa T, Matsumoto K, Ohmichi H, et al. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 1998; 18: 345-348.
65. Tsuzuki N, Miyazawa T, Matsumoto K, et al. Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats. Neurol Res 2001; 23: 417-424.
66. Tsuzuki N, Miyazawa T, Matsumoto K, et al. Hepatocyte growth factor reduces infarct volume after transient focal cerebral ischemia in rats. Acta Neurochir Suppl 2000; 76: 311-316.
67. Niimura M, Takagi N, Takagi K, et al. Effects of hepatocyte growth factor on phosphorylation of extracellular signal-regulated kinase and hippocampal cell death in rats with transient forebrain ischemia. Eur J Pharmacol 2006; 535: 114-124.
68. Niimura M, Takagi N, Takagi K, et al. Prevention of apoptosisinducing factor translocation is a possible mechanism for protective effects of hepatocyte growth factor against neuronal cell death in the hippocampus after transient forebrain ischemia. J Cereb Blood Flow Metab 2006; 26: 1354-1365.
69. Niimura M, Takagi N, Takagi K, et al. The protective effect of hepatocyte growth factor against cell death in the hippocampus after transient forebrain ischemia is related to the improvement of apurinic/apyrimidinic endonuclease/redox factor-1 level and inhibition of NADPH oxidase activity. Neurosci Lett 2006; 407: 136-140.
70. Hayashi K, Morishita R, Nakagami H, et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Ther 2001; 8: 1167-1173.
71. Shimamura M, Sato N, Waguri S, et al. Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension 2006; 47: 742-751.
72. Ishihara N, Takagi N, Niimura M, et al. Inhibition of apoptosisinducing factor translocation is involved in protective effects of hepatocyte growth factor against excitotoxic cell death in cultured hippocampal neurons. J Neurochem 2005; 95: 1277-1286.
73. Cregan SP, Dawson VL, Slack RS. Role of AIF in caspasedependent and caspase-independent cell death. Oncogene 2004; 23: 2785-2796.
74. Yu SW, Wang H, Dawson TM, Dawson VL. Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol Dis 2003; 14: 303-317.
75. Date I, Takagi N, Takagi K, et al. Hepatocyte growth factor improved learning and memory dysfunction of microsphereembolized rats. J Neurosci Res 2004; 78: 442-453.
76. Shang J, Deguchi K, Yamashita T, et al. Antiapoptotic and antiautophagic effects of glial cell line-derived neurotrophic factor and hepatocyte growth factor after transient middle cerebral artery occlusion in rats. J Neurosci Res 2010; 88: 2197-2206.
77. Shimamura M, Sato N, Oshima K, et al. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 2004; 109: 424-431.
78. Zhao MZ, Nonoguchi N, Ikeda N, et al. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metab 2006; 26: 1176-1188.
79. Date I, Takagi N, Takagi K, et al. Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction. Biochem Biophys Res Commun 2004; 319: 1152-1158.
80. Date I, Takagi N, Takagi K, et al. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci Lett 2006; 407: 141-145.
81. Takeo S, Takagi N, Takagi K, et al. Hepatocyte growth factor suppresses ischemic cerebral edema in rats with microsphere embolism. Neurosci Lett 2008; 448: 125-129.
82. Matsumoto K, Nakamura T, Sakai K, Nakamura T. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4. Proteomics 2008; 8: 3360-3370.
83. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 1998; 27: 1-39.
84. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101-112.
85. Takeuchi D, Sato N, Shimamura M, et al. Alleviation of Abetainduced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model. Gene Ther 2008; 15: 561-571.
86. Figurov A, Pozzo-Miller LD, Olafsson P, et al. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996; 381: 706-709.
87. Tyndall SJ, Walikonis RS. The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle 2006; 5: 1560-1568.
88. Akimoto M, Baba A, Ikeda-Matsuo Y, et al. Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience 2004; 128: 155-162.
89. Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 2004; 5: 771-781.
90. Shastry BS. Parkinson disease: etiology, pathogenesis and future of gene therapy. Neurosci Res 2001; 41: 5-12.
91. Koike H, Ishida A, Shimamura M, et al. Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocytegrowth factor in rodent model: a model of gene therapy for Parkinson's disease. Gene Ther 2006; 13: 1639-1644.
92. Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994; 59: 401-415.
93. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig:deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2: 806-819.
94. Cheah BC, Vucic S, Krishnan AV, Kiernan MC. Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 2010; 17: 1942-1959.
95. Siciliano G, Carlesi C, Pasquali L, et al. Clinical trials for neuroprotection in ALS. CNS Neurol Disord Drug Targets 2010; 9: 305-313.
96. Ishigaki A, Aoki M, Nagai M, et al. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. J Neuropathol Exp Neurol 2007; 66: 1037-1044.
97. Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 2006; 23: 264-280.
98. Okura Y, Arimoto H, Tanuma N, et al. Analysis of neurotrophic effects of hepatocyte growth factor in the adult hypoglossal nerve axotomy model. Eur J Neurosci 1999; 11: 4139-4144.
99. Hayashi Y, Kawazoe Y, Sakamoto T, et al. Adenoviral gene transfer of hepatocyte growth factor prevents death of injured adult motoneurons after peripheral nerve avulsion. Brain Res 2006; 1111: 187-195.
100. Powell EM, Campbell DB, Stanwood GD, et al. Genetic disruption of cortical interneuron development causes region-and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 2003; 23: 622-631.
101. Isogawa K, Akiyoshi J, Kodama K, et al. Anxiolytic effect of hepatocyte growth factor infused into rat brain. Neuropsychobiology 2005; 51: 34-38.
102. Wakatsuki M, Akiyoshi J, Ichioka S, et al. Administration of antisense DNA for hepatocyte growth factor causes an depressive and anxiogenic response in rats. Neuropeptides 2007; 41: 477-483.
103. Tada T, Zhan H, Tanaka Y, et al. Intraventricular administration of hepatocyte growth factor treats mouse communicating hydrocephalus induced by transforming growth factor beta1. Neurobiol Dis 2006; 21: 576-586.
104. Bae MH, Bissonette GB, Mars WM, et al. Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility. Exp Neurol 2010; 221: 129-135.
105. Machida S, Tanaka M, Ishii T, et al. Neuroprotective effect of hepatocyte growth factor against photoreceptor degeneration in rats. Invest Ophthalmol Vis Sci 2004; 45: 4174-4182.
106. Oshima K, Shimamura M, Mizuno S, et al. Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J 2004; 18: 212-214.
107. Tsuchihara T, Ogata S, Nemoto K, et al. Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathicpain-related phenomena in rats. Mol Ther 2009; 17: 42-50.
108. Funakoshi H, Kadoyama K, Ohya W, Nakamura T. Neuroprotective role of HGF and its molecular mecahnisms. Clinical Neuroscience 2007; 25: 620 (in Japanese).
109. Yoshimura S, Morishita R, Hayashi K, et al. Gene transfer of hepatocyte growth factor to subarachnoid space in cerebralhypoperfusion model. Hypertension 2002; 39: 1028-1034.
110. Ohtaka K, Machida S, Ohzeki T, et al. Protective effect of hepatocyte growth factor against degeneration of the retinal pigment epithelium and photoreceptor in sodium iodate-injected rats. Curr Eye Res 2006; 31: 347-355.
111. Inaoka T, Nakagawa T, Kikkawa YS, et al. Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs. Acta Otolaryngol 2009; 129: 453-457.
112. Koyama J, Yokouchi K, Fukushima N, et al. Neurotrophic effect of hepatocyte growth factor on neonatal facial motor neurons. Neurol Res 2003; 25: 701-707.
113. Kato N, Nemoto K, Nakanishi K, et al. Nonviral HVJ (hemagglutinating virus of Japan) liposome-mediated retrograde gene transfer of human hepatocyte growth factor into rat nervous system promotes functional and histological recovery of the crushed nerve. Neurosci Res 2005; 52: 299-310.
114. Kato N, Nemoto K, Nakanishi K, et al. Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. Diabetes 2005; 54: 846-854.
115. Hobara N, Yoshida N, Goda M, et al. Neurotrophic effect of hepatic growth factor (HGF) on reinnervation of perivascular calcitonin gene-related peptide (CGRP)-containing nervesfollowing phenol-induced nerve injury in the rat mesenteric artery. J Pharmacol Sci 2008; 108: 495-504.
116. Li Z, Peng J, Wang G, et al. Effects of local release of hepatocyte growth factor on peripheral nerve regeneration in acellular nerve grafts. Exp Neurol 2008; 214: 47-54.